AMH
Basic information
Region (hg38): 19:2249309-2252073
Links
Phenotypes
GenCC
Source:
- persistent Mullerian duct syndrome (Supportive), mode of inheritance: AR
- persistent Mullerian duct syndrome (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Persistent Mullerian duct syndrome, type I | AR | Endocrine; Oncologic; Genitourinary | In males, recognition can allow surveillance and surgical explorations to correct manifestations such as cryptorchdisim, which can be important to preserve fertility and decrease the chance of related sequelae (eg, testicular tumors) | Endocrine; Genitourinary; Oncologic | 8872466; 8895659; 11760020; 15878900; 18547961; 22188863 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (4 variants)
- Persistent Mullerian duct syndrome (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the AMH gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 32 | 39 | ||||
missense | 68 | 10 | 86 | |||
nonsense | 3 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 1 | 1 | 2 | |||
non coding | 8 | |||||
Total | 7 | 2 | 68 | 45 | 17 |
Highest pathogenic variant AF is 0.0000855
Variants in AMH
This is a list of pathogenic ClinVar variants found in the AMH region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-2249331-C-T | AMH-related disorder | Likely benign (Aug 12, 2024) | ||
19-2249337-G-A | Inborn genetic diseases | Conflicting classifications of pathogenicity (Feb 28, 2023) | ||
19-2249355-G-C | Uncertain significance (Dec 01, 2023) | |||
19-2249357-C-A | Inborn genetic diseases | Uncertain significance (Nov 22, 2022) | ||
19-2249367-T-G | AMH-related disorder | Uncertain significance (Oct 14, 2024) | ||
19-2249384-G-A | Inborn genetic diseases | Uncertain significance (Dec 05, 2022) | ||
19-2249385-C-T | Likely benign (Nov 27, 2023) | |||
19-2249408-A-G | Uncertain significance (Sep 24, 2021) | |||
19-2249423-G-T | Inborn genetic diseases | Uncertain significance (May 13, 2024) | ||
19-2249460-T-C | Inborn genetic diseases | Uncertain significance (Aug 26, 2022) | ||
19-2249461-G-A | Likely benign (Jan 12, 2024) | |||
19-2249468-C-G | not specified | Uncertain significance (Jun 01, 2024) | ||
19-2249469-C-A | Inborn genetic diseases | Uncertain significance (Dec 14, 2023) | ||
19-2249478-G-T | Persistent Mullerian duct syndrome | Benign (Jan 31, 2024) | ||
19-2249482-AC-A | Persistent Mullerian duct syndrome | Pathogenic (Dec 22, 2019) | ||
19-2249498-C-T | Likely benign (Oct 03, 2023) | |||
19-2249506-A-G | not specified | Likely benign (May 22, 2019) | ||
19-2249512-C-T | Likely benign (Apr 23, 2023) | |||
19-2249534-T-TC | Pathogenic (Mar 14, 2024) | |||
19-2249559-T-C | Uncertain significance (Dec 01, 2023) | |||
19-2249564-G-A | Uncertain significance (Feb 24, 2022) | |||
19-2249583-T-A | Uncertain significance (Nov 16, 2021) | |||
19-2249583-T-C | Inborn genetic diseases | Uncertain significance (Feb 16, 2023) | ||
19-2249584-G-A | Benign (Jan 29, 2024) | |||
19-2249605-C-T | AMH-related disorder | Likely benign (Dec 31, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
AMH | protein_coding | protein_coding | ENST00000221496 | 5 | 2765 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.40e-12 | 0.0123 | 124927 | 0 | 39 | 124966 | 0.000156 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.881 | 336 | 294 | 1.14 | 0.0000194 | 3296 |
Missense in Polyphen | 143 | 124.41 | 1.1495 | 1462 | ||
Synonymous | -1.32 | 163 | 143 | 1.14 | 0.00000982 | 1330 |
Loss of Function | -0.701 | 16 | 13.2 | 1.21 | 7.45e-7 | 137 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000778 | 0.000592 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000112 | 0.000109 |
Finnish | 0.000192 | 0.000185 |
European (Non-Finnish) | 0.000148 | 0.000133 |
Middle Eastern | 0.000112 | 0.000109 |
South Asian | 0.000102 | 0.0000980 |
Other | 0.000342 | 0.000328 |
dbNSFP
Source:
- Function
- FUNCTION: This glycoprotein, produced by the Sertoli cells of the testis, causes regression of the Muellerian duct. It is also able to inhibit the growth of tumors derived from tissues of Muellerian duct origin.;
- Disease
- DISEASE: Persistent Muellerian duct syndrome 1 (PMDS1) [MIM:261550]: A form of male pseudohermaphroditism characterized by a failure of Muellerian duct regression in otherwise normal males. {ECO:0000269|PubMed:8162013, ECO:0000269|PubMed:8872466}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- TGF-beta signaling pathway - Homo sapiens (human);Hippo signaling pathway - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Cytokine-cytokine receptor interaction - Homo sapiens (human);TGF-Core;Mesodermal Commitment Pathway;Signal Transduction;Signaling by BMP;Signaling by TGF-beta family members;ALK2 signaling events
(Consensus)
Haploinsufficiency Scores
- pHI
- 0.346
- hipred
- N
- hipred_score
- 0.220
- ghis
- 0.438
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.768
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Amh
- Phenotype
- endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; reproductive system phenotype; neoplasm;
Zebrafish Information Network
- Gene name
- amh
- Affected structure
- spermatogonium
- Phenotype tag
- abnormal
- Phenotype quality
- increased amount
Gene ontology
- Biological process
- preantral ovarian follicle growth;urogenital system development;Mullerian duct regression;cell-cell signaling;gonadal mesoderm development;sex determination;sex differentiation;aging;regulation of signaling receptor activity;positive regulation of gene expression;response to organic cyclic compound;BMP signaling pathway;response to drug;positive regulation of NF-kappaB transcription factor activity;negative regulation of ovarian follicle development
- Cellular component
- extracellular region;extracellular space
- Molecular function
- signaling receptor binding;transforming growth factor beta receptor binding;hormone activity;growth factor activity